Research Grants for Preventing Interpersonal Violence and Suicide Among Youth and Young Adults (R01)

The Research Grants for Preventing Interpersonal Violence and Suicide Among Youth and Young Adults (R01) program is administered by the Centers for Disease Control and Prevention (CDC), specifically through the National Center for Injury Prevention and Control (NCIPC) within the U.S. Department of Health and Human Services. This funding opportunity reflects the CDC’s long-standing leadership in violence and injury prevention research and its commitment to advancing evidence-based public health strategies. The program is designed to support investigator-led research that addresses critical gaps in understanding how to prevent interpersonal violence and suicide among youth and young adults, defined as individuals ages 10 to 24. The primary purpose of this grant is to fund rigorous effectiveness research evaluating innovative or adapted prevention strategies. The CDC prioritizes approaches that have not yet been thoroughly evaluated but show strong theoretical or empirical promise in reducing violence or suicide risk. The opportunity supports three main objectives: evaluating innovative interventions with near-term benefits, assessing implementation factors that improve existing evidence-based strategies, and studying approaches that address multiple forms of violence or suicide simultaneously. Research topics of interest include adverse childhood experiences, intimate partner and sexual violence, youth violence, suicide prevention, and cross-cutting strategies that address shared risk factors. Funding is structured as a discretionary grant with an expected total program allocation of $9.6 million and approximately eight awards. Each award may provide up to $400,000 per year over a three-year performance period, divided into 12-month budget cycles. Funds are intended to support research activities including data collection, analysis, evaluation design, and dissemination. However, there are restrictions on allowable costs, including prohibitions on clinical care (except where permitted), lobbying activities, and certain capital expenditures. The program does not require cost sharing or matching funds, although voluntary contributions may be included without influencing review outcomes. Eligibility for this opportunity is broad and inclusive, encompassing a wide range of organizational types. Eligible applicants include state and local governments, tribal entities, public and private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations, and small businesses. Applicants must demonstrate the capacity to conduct rigorous research, including having qualified principal investigators with relevant experience in violence or suicide prevention research. Collaborative partnerships are encouraged, particularly those involving community organizations, but the primary applicant must retain leadership and responsibility for the project. The application process requires submission through Grants.gov and includes multiple required components such as the SF-424 forms, a detailed research plan, budget justification, and supporting documentation like letters of support and data sharing agreements. Applicants must adhere strictly to formatting and content guidelines outlined in the NOFO and NIH research instructions. Evaluation of applications follows a two-tiered merit review process, assessing criteria such as significance, innovation, approach, investigator qualifications, and research environment. Additional considerations include alignment with CDC priorities, geographic distribution, and portfolio balance. Key dates for this funding opportunity include an optional letter of intent deadline of June 15, 2026, and a required application submission deadline of July 1, 2026 at 11:59 PM Eastern Time. An informational webinar is scheduled for June 8, 2026. Review processes are expected to occur in late July and early August, with anticipated award notifications by August 28, 2026 and project start dates around September 30, 2026. While this specific opportunity does not explicitly state recurrence, similar CDC research funding announcements are typically released periodically, suggesting the potential for future cycles. Applicants are encouraged to align their proposals with CDC priorities, including evidence-based practice, transparency, and public health impact. For additional support or questions, applicants may contact the program’s scientific lead via email. Overall, this grant represents a significant opportunity for organizations to contribute to national efforts in reducing violence and suicide among vulnerable youth populations through high-quality research.

Ensure rigorous experimental or quasi-experimental design; align proposal with CDC priorities; clearly demonstrate PI expertise and access to data; include strong community partnerships